Encephale
-
Multicenter Study Clinical Trial
[Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
Injectable risperidone is the first long-acting second-generation antipsychotic. A middle-term naturalistic study has been conducted with the first treated patients of three psychiatric hospitals in Aquitaine. ⋯ Despite the small size of the sample, this study presents a view of the use of the drug in realistic conditions and appears to show that long-acting injectable risperidone is probably the most appropriate treatment for stable, discharged patients.